Filtros de búsqueda

Lista de obras de David Preiss

A systematic review of event rates in clinical trials in diabetes mellitus: the importance of quantifying baseline cardiovascular disease history and proteinuria and implications for clinical trial design

scientific article published on January 2011

Ambient temperature and pseudohyperkalaemia

artículo científico publicado en 2006

Applying metabolomics to cardiometabolic intervention studies and trials: past experiences and a roadmap for the future

artículo científico publicado en 2016

Association of Lipid Fractions With Risks for Coronary Artery Disease and Diabetes

artículo científico publicado en 2016

Biochemistry laboratories should routinely report non-HDL-cholesterol

artículo científico publicado en 2015

Body Mass Index and Risk of Nonalcoholic Fatty Liver Disease: Two Electronic Health Record Prospective Studies

artículo científico publicado en 2015

Cardiac Troponin T and Troponin I in the General Population

artículo científico publicado en 2019

Cardiovascular disease: PCSK9 inhibition: a new player in cholesterol-lowering therapies?

artículo científico publicado en 2017

Change in levels of physical activity after diagnosis of type 2 diabetes: an observational analysis from the NAVIGATOR study

artículo científico publicado en 2014

Choice of medical therapy to lower triglycerides in those at risk of pancreatitis

artículo científico publicado en 2013

Cholesterol- and blood-pressure-lowering drug use for secondary cardiovascular prevention in 2004-2013 Europe

artículo científico publicado en 2016

Cholesteryl Ester Transfer Protein Inhibition for Preventing Cardiovascular Events: JACC Review Topic of the Week

article

Classification of reported statin intolerance

Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients With Heart Failure and Preserved Ejection Fraction: A Report From the I-Preserve Trial (Irbesartan in Heart Failure With Preserved Ej

artículo científico

Combined Free Light Chains Are Novel Predictors of Prognosis in Heart Failure.

artículo científico publicado en 2015

Combined cardiovascular and diabetes risk assessment in primary care

artículo científico publicado en 2011

Comparison between High-Sensitivity Cardiac Troponin T and Cardiac Troponin I in a Large General Population Cohort

artículo científico publicado en 2018

Comparison of PCSK9 Inhibitor Evolocumab vs Ezetimibe in Statin-Intolerant Patients: Design of the Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin-Intolerant Subjects 3 (GAUSS-3) Trial.

artículo científico publicado en 2016

Comparison of outcomes after hospitalization for worsening heart failure, myocardial infarction, and stroke in patients with heart failure and reduced and preserved ejection fraction

artículo científico publicado en 2014

Contrasting associations of insulin resistance with diabetes, cardiovascular disease and all-cause mortality in the elderly: PROSPER long-term follow-up

artículo científico publicado en 2014

Diabetic microvascular complications as simple indicators of risk for cardiovascular outcomes and heart failure

artículo científico publicado en 2016

Diagnosing unsuspected hypopituitarism in adults from suggestive thyroid function test results

artículo científico publicado en 2008

Do statins reduce microvascular complications in diabetes?

artículo científico publicado en 2014

Does the LDL Receptor Play a Role in the Risk of Developing Type 2 Diabetes?

scientific article published in The Journal of the American Medical Association

Effect of Evolocumab on Lipoprotein Particles

artículo científico publicado en 2017

Effect of Rosuvastatin on Fatigue in Patients With Heart Failure

article

Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials

artículo científico publicado en 2009

Effect of metformin therapy on circulating amino acids in a randomized trial: the CAMERA study

artículo científico publicado en 2016

Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysis

artículo científico publicado en 2016

Effect of the Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Evolocumab on Glycemia, Body Weight, and New-Onset Diabetes Mellitus

artículo científico

Efficacy and Safety of the PCSK9 Inhibitor Evolocumab in Patients with Mixed Hyperlipidemia

artículo científico publicado en 2016

Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical Trial

artículo científico

Emerging therapeutic approaches to treat dyslipidemia

artículo científico

Eplerenone and new-onset diabetes in patients with mild heart failure: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF).

artículo científico publicado en 2012

Erratum to: Efficacy and Safety of the PCSK9 Inhibitor Evolocumab in Patients with Mixed Hyperlipidemia.

artículo científico publicado en 2016

Erratum to: SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms?

artículo científico publicado en 2016

Event Rates in Trials of Patients With Type 2 Diabetes

scientific article published in The Journal of the American Medical Association

Ezetimibe: Likely to Be Beneficial For All

artículo científico publicado en 2018

Falling Cardiovascular Mortality in Heart Failure With Reduced Ejection Fraction and Implications for Clinical Trials.

artículo científico

Fasting plasma glucose in non-diabetic participants and the risk for incident cardiovascular events, diabetes, and mortality: results from WOSCOPS 15-year follow-up

artículo científico publicado en 2010

Genetic insights into statin-associated diabetes risk

artículo científico publicado en 2016

HARMONY or discord in cardiovascular outcome trials of GLP-1 receptor agonists?

artículo científico publicado en 2018

HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials

artículo científico publicado en 2014

HbA1c in type 2 diabetes diagnostic criteria: addressing the right questions to move the field forwards

artículo científico publicado en 2012

HbA1c: a useful cardiovascular risk marker in those without diabetes?

scientific article published on 11 September 2010

How to measure renal function in clinical practice: eating cooked meat alters serum creatinine concentration and eGFR significantly

artículo científico publicado en 2006

Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review

artículo científico publicado en 2011

Intensive glucose lowering treatment in type 2 diabetes

artículo científico publicado en 2011

Interpretation of the evidence for the efficacy and safety of statin therapy

artículo científico publicado en 2016

Lipid-lowering efficacy of the PCSK9 inhibitor evolocumab (AMG 145) in patients with type 2 diabetes: a meta-analysis of individual patient data

artículo científico publicado en 2016

Lipid-modifying therapies and risk of pancreatitis: a meta-analysis

artículo científico publicado en 2012

Lipids, lipid modifying agents and cardiovascular risk: a review of the evidence

artículo científico publicado en 2008

Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data

artículo científico publicado en 2010

Mendelian randomisation study for statin treatment – Authors' reply

artículo científico publicado en 2015

Metabolic syndrome, dysglycaemia and vascular disease: making sense of the evidence

artículo científico publicado en 2007

Metabolic syndrome: collapsing under its own weight?

artículo científico publicado en 2009

Metformin Therapy and Circulating NT-proBNP Levels: The CAMERA Trial

artículo científico publicado en 2016

Metformin and lactic acidosis. Metformin: framed again?

artículo científico publicado en 2009

Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial.

artículo científico publicado en 2013

Niacin therapy and the risk of new-onset diabetes: a meta-analysis of randomised controlled trials

artículo científico

Non-alcoholic fatty liver disease

artículo científico publicado en 2014

Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations

artículo científico publicado en 2008

PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study

artículo científico publicado en 2016

PCSK9 inhibition: the dawn of a new age in cholesterol lowering?

artículo científico publicado en 2016

Phenome-wide association analysis of LDL-cholesterol lowering genetic variants in PCSK9

scientific article published on 29 October 2019

Physical activity as a determinant of fasting and 2-h post-challenge glucose: a prospective cohort analysis of the NAVIGATOR trial

artículo científico publicado en 2015

Pooled Safety Analysis of Evolocumab in Over 6000 Patients From Double-Blind and Open-Label Extension Studies

artículo científico publicado en 2017

Prediction of Cardiovascular Disease Risk by Cardiac Biomarkers in 2 United Kingdom Cohort Studies: Does Utility Depend on Risk Thresholds For Treatment?

artículo científico publicado en 2015

Predictors of cardiovascular events in a contemporary population with impaired glucose tolerance: an observational analysis of the Nateglinide and Valsartan in impaired glucose tolerance outcomes research (NAVIGATOR) trial

artículo científico publicado en 2012

Predictors of development of diabetes in patients with chronic heart failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) program

artículo científico publicado en 2009

Predictors of stroke in patients with impaired glucose tolerance: results from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial

artículo científico publicado en 2013

Prospective relationships between body weight and physical activity: an observational analysis from the NAVIGATOR study

artículo científico publicado en 2015

Reducing cardiovascular risk in type 2 diabetes mellitus

Reply

Research digest

artículo científico publicado en 2016

Research digest

artículo científico publicado en 2016

Research digest: CV trials in diabetes-looking ahead

artículo científico publicado en 2018

Research digest: NAFLD in the spotlight

artículo científico publicado en 2016

Research digest: SGLT2 inhibition in kidney and liver disease

artículo científico publicado en 2019

Research digest: assessment and risks of obesity

artículo científico publicado en 2018

Research digest: cardiac biomarkers for risk prediction

scientific article published on 12 October 2016

Research digest: genetics in cardiometabolic disease

scientific article published on 01 December 2018

Research digest: heart failure in diabetes comes into focus

scientific article published on 01 August 2018

Research digest: hypoglycaemia and glucose variability

artículo científico publicado en 2017

Research digest: more cardiovascular outcome trials in diabetes

artículo científico publicado en 2017

Research digest: new insights into established risk pathways

scientific article published on 01 April 2019

Research digest: prediabetes definitions and diabetes prevention

artículo científico publicado en 2017

Research digest: progress in microvascular complications

artículo científico publicado en 2018

Research digest: the risks of type 2 diabetes at a young age

artículo científico publicado en 2017

Research digest: topical trials in thyroid disease

scientific article published on 07 June 2017

Research digest: updates on diabetes in pregnancy

artículo científico publicado en 2018

Research digest: vitamin D supplementation

scientific article published on 01 February 2019

Research digest: weight loss to prevent and treat diabetes

artículo científico publicado en 2016

Reverse Causality in Cardiovascular Epidemiological Research: More Common Than Imagined?

artículo científico publicado en 2017

Risk Related to Pre-Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction: Insights From Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial

artículo científico publicado en 2016

Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis

artículo científico publicado en 2011

SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms?

artículo científico publicado en 2016

Screening for diabetes in patients with cardiovascular disease: HbA1c trumps oral glucose tolerance testing.

artículo científico publicado en 2016

Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association

artículo científico publicado en 2019

Statin therapy and new-onset diabetes: A cause for concern? ⬇️

artículo científico publicado el 22 de marzo de 2012

Statins and new-onset diabetes—the important questions ⬇️

artículo científico publicado el 14 de febrero de 2012

Statins and risk of incident diabetes – Authors' reply

artículo científico publicado en 2010

Statins and the risk of new-onset diabetes: a review of recent evidence

artículo científico publicado en 2011

Sustained influence of metformin therapy on circulating glucagon-like peptide-1 levels in individuals with and without type 2 diabetes.

artículo científico publicado en 2016

The Role of Emerging Risk Factors in Cardiovascular Outcomes

artículo científico publicado en 2017

The case for diabetes screening: ADDITION-Europe

scientific article published on 24 June 2011

The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials

artículo científico publicado en 2015

The effects of 8 months of metformin on circulating GGT and ALT levels in obese women with polycystic ovarian syndrome

artículo científico publicado en 2008

The emergence of proton nuclear magnetic resonance metabolomics in the cardiovascular arena as viewed from a clinical perspective

artículo científico publicado en 2014

The incremental prognostic and clinical value of multiple novel biomarkers in heart failure

artículo científico publicado en 2016

The influence of a cooked-meat meal on estimated glomerular filtration rate

artículo científico publicado en 2007

The insulin resistance syndrome

The inverse relationship between alanine aminotransferase in the normal range and adverse cardiovascular and non-cardiovascular outcomes

scientific article published on 17 November 2011

The new pooled cohort equations risk calculator

artículo científico

The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY study

artículo científico publicado en 2018

Tightening our understanding of intensive glycaemic control

artículo científico publicado en 2017

Treatment of severe hypertriglyceridaemia

artículo científico publicado en 2014

Triglyceride levels, pancreatitis and choice of lipid-modifying therapy

scientific article published on 01 March 2013

Vascular cell adhesion molecule-1: a viable therapeutic target for atherosclerosis?

artículo científico publicado en 2007

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda